Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy

Fludarabine-based regimens and CHOP (doxorubicin, cyclophosphamide, vincristine, prednisone)-like regimens with or without rituximab are the most common treatment modalities for indolent lymphoma. However, there is no clear evidence to date about which chemotherapy regimen should be the proper initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao-xiao, Yan, Bei, Wang, Zhen-xing, Yu, Yong, Wu, Xiao-xiong, Zhang, Yi-zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797259/
https://www.ncbi.nlm.nih.gov/pubmed/24143112
http://dx.doi.org/10.2147/OTT.S47764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797259/
https://www.ncbi.nlm.nih.gov/pubmed/24143112
http://dx.doi.org/10.2147/OTT.S47764

Ejemplares similares